Welcome to our dedicated page for AINOS news (Ticker: AIMDW), a resource for investors and traders seeking the latest updates and insights on AINOS stock.
Ainos, Inc. reports developments for a dual-platform AI and biotechnology business built around AI Nose smelltech and VELDONA low-dose oral interferon therapeutics. Its news centers on commercialization of AI Nose, an electronic olfaction platform that uses sensor arrays, proprietary AI models and a Smell Language Model to convert scent and volatile organic compound signals into Smell ID data.
Recurring updates cover industrial and semiconductor deployments, hospital and environmental monitoring partnerships, smart factory and robotics applications, subscription-based platform economics, financing activity and periodic financial results. Company announcements also track the positioning of digital olfaction as an AI perception layer alongside continuing references to immune-therapeutic development.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.